配对血浆滤过吸附治疗重症急性胰腺炎的随机对照研究

被引:9
作者
何朝生 [1 ,2 ]
史伟 [2 ]
梁馨苓 [2 ]
叶智明 [2 ]
章斌 [2 ]
刘双信 [2 ]
马建超 [2 ]
冯仲林 [2 ]
机构
[1] 南方医科大学
[2] 广东省人民医院肾内科//广东省医学科学院
基金
广东省科技计划;
关键词
配对血浆分离吸附法; 连续性血液净化; 重症急性胰腺炎;
D O I
暂无
中图分类号
R576 [胰腺疾病];
学科分类号
100201 [内科学];
摘要
【目的】观察配对血浆分离吸附法(CPFA)对重症急性胰腺炎(SAP)患者病情发展的影响、临床疗效和安全性,并探讨其治疗机制。【方法】将30例重症急性胰腺炎(SAP)患者随机分为两组,治疗组15例采用CPFA技术治疗,对照组15例采用常规连续性静脉-静脉血液滤过(CVVH)治疗,所有患者均在ICU监护中,30例患者比较治疗过程的平均动脉压、Pa O2/Fi O2、TNF-α、IL-1β、IL-6、IL-10、肝肾功能生化指标、血、尿淀粉酶、临床改善程度以及APACHEⅡ评分的改善,同时观察治疗的副作用,同时随访病人的预后,统计分析其存活率。【结果】两组间治疗前病情的严重程度基本无差异(P<0.05),CPFA治疗组患者在治疗平均动脉压、Pa O2/Fi O2明显上升(P<0.05),促炎症因子TNF-α、IL-1β、IL-6等因子明显降低(P<0.05),抗炎症因子IL-10增加(P<0.05),与对照组相比均有统计学差异(P<0.05),治疗组治疗后APACHEⅡ评分呈下降趋势,至第10天明显低于治疗前和对照组(P<0.05),治疗组未发生休克、出血、过敏等严重并发症,耐受好,并发症的发生率无统计学差异(与对照组相比);治疗组存活率12/15(80%)明显高于对照组7/15(46.7%;P<0.05)。【结论】CPFA可有效调整机体的免疫功能,改善重症急性胰腺炎患者的预后,提高存活率,而且无明显不良反应,值得在临床上推广。
引用
收藏
页码:877 / 882
页数:6
相关论文
共 11 条
[1]
In Vivo Antibiotic Removal During Coupled Plasma Filtration Adsorption: A Retrospective Study [J].
Page, Mathieu ;
Cohen, Sabine ;
Ber, Charles-Eric ;
Allaouchiche, Bernard ;
Kellum, John A. ;
Rimmele, Thomas .
ASAIO JOURNAL, 2014, 60 (01) :70-75
[2]
Coupled plasma filtration adsorption [J].
Bellomo, R ;
Tetta, C ;
Ronco, C .
INTENSIVE CARE MEDICINE, 2003, 29 (08) :1222-1228
[3]
Hemodynamic response to coupled plasmafiltration-adsorption in human septic shock [J].
Formica, M ;
Olivieri, C ;
Livigni, S ;
Cesano, G ;
Vallero, A ;
Maio, M ;
Tetta, C .
INTENSIVE CARE MEDICINE, 2003, 29 (05) :703-708
[4]
A pilot study of coupled plasma filtration with adsorption in septic shock*.[J].Claudio Ronco;Alessandra Brendolan;Gerhard Lonnemann;Rinaldo Bellomo;Pasquale Piccinni;Antonio Digito;Maurizio Dan;Marco Irone;Giuseppe La Greca;Paola Inguaggiato;Umberto Maggiore;Concetta De Nitti;Mary Lou Wratten;Zaccaria Ricci;Ciro Tetta.Critical Care Medicine.2002, 6
[5]
Attenuation of sepsis-related immunoparalysis by continuous venovenous hemofiltration in experimental porcine pancreatitis [J].
Yekebas, EF ;
Eisenberger, CF ;
Ohnesorge, H ;
Saalmüller, A ;
Elsner, HA ;
Engelhardt, M ;
Gillesen, A ;
Meins, J ;
The, M ;
Strate, T ;
Busch, C ;
Knoefel, WT ;
Bloechle, C ;
Izbicki, JR .
CRITICAL CARE MEDICINE, 2001, 29 (07) :1423-1430
[6]
High-volume haemofiltration in human septic shock [J].
Cole, L ;
Bellomo, R ;
Journois, D ;
Davenport, P ;
Baldwin, I ;
Tipping, P .
INTENSIVE CARE MEDICINE, 2001, 27 (06) :978-986
[7]
Can inflammatory cytokines be removed efficiently by continuous renal replacement therapies? [J].
De Vriese, AS ;
Vanholder, RC ;
Pascual, M ;
Lameire, NH ;
Colardyn, FA .
INTENSIVE CARE MEDICINE, 1999, 25 (09) :903-910
[8]
Acute pancreatitis: Nonsurgical management [J].
Tenner, S ;
Banks, PA .
WORLD JOURNAL OF SURGERY, 1997, 21 (02) :143-148
[9]
INTERLEUKIN-6 AND INTERLEUKIN-8 EXTRACTION DURING CONTINUOUS VENOVENOUS HEMODIAFILTRATION IN SEPTIC ACUTE-RENAL-FAILURE [J].
BELLOMO, R ;
TIPPING, P ;
BOYCE, N .
RENAL FAILURE, 1995, 17 (04) :457-466
[10]
REMOVAL OF PRO-INFLAMMATORY CYTOKINES WITH RENAL REPLACEMENT THERAPY - SENSE OR NONSENSE [J].
SCHETZ, M ;
FERDINANDE, P ;
VANDENBERGHE, G ;
VERWAEST, C ;
LAUWERS, P .
INTENSIVE CARE MEDICINE, 1995, 21 (02) :169-176